Copyright
©The Author(s) 2000.
World J Gastroenterol. Dec 15, 2000; 6(6): 855-860
Published online Dec 15, 2000. doi: 10.3748/wjg.v6.i6.855
Published online Dec 15, 2000. doi: 10.3748/wjg.v6.i6.855
Figure 1 DNA ladder of Ad-RA538 on SGC7901 cells.
lane 1: Ad-lac Z (2d); lane 2: Ad-RA538 (2d);lane 3: Ad-lacZ (4d); lane 4: Ad RA538 (4d);lane 5: Ad-lacZ (6d); lane 6: Ad-RA538 (6d).
Figure 2 TUNEL assay of Ad-RA538 and Ad-LacZ on SGC 7901 cells.
Figure 3 Western blot analysis c-myc and β-actin expression of SGC7901 cell infected with Ad-RA538.
Lane 1: control, Lane 2-5: 1d, 3d, 5d, 7d.
Figure 4 Tumorigenicity assay in nude mice follow AdRA538.
Figure 5 In vivo therapy of Ad-RA538 on SGC7901 tumors in nude mice.
Figure 6 Experimental therapy on the nude mice model of AdRA538.
- Citation: Chen JP, Lin C, Xu CP, Zhang XY, Wu M. The therapeutic effects of recombinant adenovirus RA538 on human gastric carcinoma cells in vitro and in vivo. World J Gastroenterol 2000; 6(6): 855-860
- URL: https://www.wjgnet.com/1007-9327/full/v6/i6/855.htm
- DOI: https://dx.doi.org/10.3748/wjg.v6.i6.855